Top Markets
Coin of the day
GSK plc GSK plc

GSK plc

GSK
Rang în acțiuni #9382
GSK plc is a global pharmaceutical and healthcare company, deeply involved in... GSK plc is a global pharmaceutical and healthcare company, deeply involved in the research, development, production, and commercialization of a diverse range of medicinal and wellness products. Its operations span the United Kingdom, the United States, and numerous other international markets. The company structures its operations across four primary divisions: Pharmaceuticals, Pharmaceutical R&D, Vaccines, and Consumer Healthcare. Within its Pharmaceuticals segment, GSK provides treatments addressing a wide array of therapeutic areas. These include respiratory conditions, HIV, immuno-inflammatory diseases, oncology, viral infections, central nervous system disorders, cardiovascular and urogenital health, metabolic imbalances, bacterial infections, and dermatological issues. The Consumer Healthcare division offers products across categories such as wellness, oral hygiene, nutritional supplements, and skin health. These consumer offerings come in a variety of formats, including oral dosage forms (e.g., tablets, syrups, lozenges, gummies, soft chews, effervescents), topical applications (e.g., gels, creams, patches, lip balms), nasal sprays, and a comprehensive range of oral hygiene products (e.g., toothpastes, mouthwashes, denture care items), alongside other specialized formulations like infant drops and wipes. GSK actively engages in various collaborative ventures. Its collaboration agreements include partnerships with 23andMe, Lyell Immunopharma, Inc., Novartis, Sanofi SA, Surface Oncology, Progentec Diagnostics, Inc., Alector, Inc., and CureVac AG. Additionally, the company maintains strategic alliances with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. Originally established in 1715, the company operated under the name GlaxoSmithKline plc until its rebranding to GSK plc in May 2022. Its corporate headquarters are situated in Brentford, United Kingdom.
Preț acțiune
$25.28
Ultima sincronizare: 2026-09-18
Capitalizare de piață
$1.01B
Schimbare (1 zi)
-2.29%
Schimbare (1 an)
-37.84%
Țară
GB
Tranzacționează GSK plc (GSK)

Categorie

Raport P/E pentru GSK plc (GSK)
Raport P/E la data de September 2026 TTM: 15.45
Conform celor mai recente rapoarte financiare și prețului acțiunilor GSK plc, raportul P/E actual (TTM) este 15.45. La sfârșitul anului 2024, compania avea un P/E de 21.32.
Istoricul raportului P/E pentru GSK plc din 2000 până în 2026
Raportul P/E la sfârșitul fiecărui an
An Raport P/E Schimbă
2026 (TTM) 15.45 19.52%
2025 12.93 -39.35%
2024 21.32 78.79%
2023 11.92 208.12%
2022 3.87 -67.35%
2021 11.85 26.27%
2020 9.39 -38.69%
2019 15.31 -6.32%
2018 16.34 -52.05%
2017 34.08 -49.33%
2016 67.26 956.89%
2015 6.36 -67.19%
2014 19.40 67.62%
2013 11.57 -1.74%
2012 11.78 3.64%
2011 11.36 -63.56%
2010 31.18 219.11%
2009 9.77 -16.60%
2008 11.72 7.01%
2007 10.95 -5.13%
2006 11.54 -19.65%
2005 14.36 -0.89%
2004 14.49 8.99%
2003 13.30 -8.11%
2002 14.47 -46.94%
2001 27.27 22.42%
2000 22.28 0.00%
Raportul P/E pentru companii similare sau concurenți
Companie P/E Ratio Diferență P/E Ratio Țara
38.12 146.64%
US
30.79 99.22%
US
73.73 377.08%
US
22.25 43.96%
CH
114.95 643.83%
US
Cum interpretezi un P/E ratio?

Raportul Preț/Câștig (P/E Ratio) măsoară relația dintre prețul acțiunii unei companii și câștigul pe acțiune.
Un P/E scăzut dar pozitiv indică o companie cu profituri mari în raport cu evaluarea actuală și ar putea fi subevaluată. Un P/E negativ mare (aproape de 0) indică pierderi majore.

Companiile cu un P/E peste 30 sau negativ sunt considerate în general „acțiuni de creștere”, adică investitorii se așteaptă la creștere sau profitabilitate viitoare.

Companiile cu un P/E pozitiv sub 10 sunt considerate „acțiuni de valoare”, adică sunt deja profitabile, dar cu șanse mici de creștere suplimentară.